Regenerex Pharma (Regenerex Pharma) Liabilities-to-Assets : 5.55 (As of Dec. 2023)

Regenerex Pharma Liabilities-to-Assets Chart

Regenerex Pharma Annual Data
	Trend	Nov09	Nov10	Nov11	Nov12	Nov13	Nov14	Mar17	Mar18	Mar22	Mar23
Liabilities-to-Assets		Get a 7-Day Free Trial					199.75	-	22.40	66.73	161.29

Regenerex Pharma Quarterly Data
	May14	Aug14	Nov14	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Liabilities-to-Assets	Get a 7-Day Free Trial															108.70	161.29	2.04	4.89	5.55

Competitive Comparison of Regenerex Pharma's Liabilities-to-Assets

For the Medical Instruments & Supplies subindustry, Regenerex Pharma's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerex Pharma's Liabilities-to-Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Regenerex Pharma's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Regenerex Pharma's Liabilities-to-Assets falls into.

Regenerex Pharma Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Regenerex Pharma's Liabilities-to-Assets Ratio for the fiscal year that ended in Mar. 2023 is calculated as:

Regenerex Pharma's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenerex Pharma  (OTCPK:PEPT) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Regenerex Pharma Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Regenerex Pharma's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenerex Pharma (Regenerex Pharma) Business Description